Cyclizine Hydrochloride
Brand Formulations & Prices
1 brands sorted by unit price
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesTravelit is indicated in-
Motion sickness: Travelit is indicated for the prevention and treatment of nausea and vomiting.
PONV (Postoperative nausea & vomiting)
Meniere's disease etc.
Motion Sickness:
Adults
: 1 Tablet (50 mg)
Children: (6 years & above)
: 1/2 Tablet (25 mg). 1 tablet should be taken at least 30 minutes before journey (before or after meal), repeat 1 tablet if journey is more than 6 hours
Postoperative Nausea & Vomiting, Meniere's disease:
Adults
: 1 Tablet (50 mg) every 6-8 hours daily
Children: (6 years & above)
: 1/2 Tablet (25 mg) every 6-8 hours daily
Hypersensitivity to the active substance or to the other excipients. Cyclizine is contraindicated in the presence of acute alcohol intoxication. The anti-emetic properties of cyclizine may increase the toxicity of alcohol.
Itching or skin rashes, swelling of the face, lips or throat, difficulty in breathing or wheeziness.
Travelit should be used with caution and appropriate monitoring in patients with glaucoma, urinary retention, obstructive disease of the gastrointestinal tract, hepatic disease, hypertension, epilepsy, severe heart failure.
Cyclizine Hydrochloride is an US FDA approved antihistaminic antiemetic drug. It possesses anticholinergic and antiemetic properties. It reduces excitability of inner ear labyrinth and acts directly on vomiting (Emetic) centre in the brain stem.